JGL d.d.-dosp 12/2029/A

3JDG3
  • {{formatNumeric(WebMarketData.high_price)}}
  • {{formatNumeric(WebMarketData.low_price)}}
{{formatNumeric(getStockValueIf(WebMarketData.close_price, WebMarketData.last_price, WebMarketData.prev_close_price))}} {{WebMarketData.CurrencyAtDate}} {{plusMinus(WebMarketData.change_prev_close_percentage) + formatNumeric(WebMarketData.change_prev_close_percentage)}} %
Previously Traded
  • Date
  • {{formatDate(DateOfFile)}}
  • -
  • Close Price
  • {{formatNumericAndCurrency(WebMarketData.close_price, Papir.price_currency)}}
  • Volume
  • {{formatNumeric(WebMarketData.volume)}}
  • -
  • Turnover
  • -

Last 52 weeks
  • High Price
  • Low Price
Previously Traded
  • Date
  • {{formatDate(DateOfFile)}}
  • -
  • Close Price
  • -
  • Volume
  • {{formatNumeric(WebMarketData2.volume)}}
  • -
  • Turnover

Last 52 weeks
  • High Price
  • Low Price
There were no trades with this instrument
Order Book
Bid Ask
# Volume Price Volume #
{{formatNumericInt(item.bid_num_orders, '')}} {{formatNumeric(item.bid_volume, '', QuantityDecimals)}} {{formatNumeric(item.bid_price, '')}} {{formatNumeric(item.ask_price, '')}} {{formatNumeric(item.ask_volume, '', QuantityDecimals)}} {{formatNumericInt(item.ask_num_orders, '')}}
Due to a corporate action, trading will continue under the new issue
The security is delisted
Trading is suspended
Trading is closed
No orders
Instrument
  • ISIN
  • HRJDGLO29CA5
  • FISN
  • JGL/4.125BD 20291203 1 UNSEC
  • Type
  • Corporate Bond
  • CFI Code
  • DBFUFR
  • Issue Date
  • 12/03/2024
  • Maturity Date
  • 12/03/2029
  • Nominal Value
  • 1.00 EUR
  • Interest Rate
  • 4.1250 %
  • Payout Period
  • 6 months
 
  • Symbol
  • 3JDG3
  • MIC
  • XZAG
  • Segment
  • Official market
  • Trading Model
  • Continuous Trading
  • First Trading Day
  • 12/06/2024
  • Listed Quantity
  • 60,000,000
  • Market Cap
  • 61.32 mil. EUR
  • Last Trading Day
  • 11/28/2029
Industry
  • Sector
  • CF · Manufacture of basic pharmaceutical products and pharmaceutical preparations
  • NACE
  • 2120 · Manufacture of pharmaceutical preparations

Trading Parameters
  • Min Order Quantity
  • 1
  • Min Block Value
  • 1,500,000.00 EUR
Iceberg Orders
  • Min Total Value
  • 10,000.00 EUR
  • Min Peak Value
  • 500.00 EUR (5 %)
Trading Safeguards
  • Max Order Size
  • 20,000,000
  • Max Order Value
  • 2,000,000.00 EUR
Volatility Interruptions
  • Category
  • D2
  • Dynamic Corridor
  • ± 15 %
  • Static Corridor
  • ± 30 %
  • Extended Volatility
  • ± 45 %
 
Ownership Structure
Seq.no. Account owner (holder) / Security co-holder (holder) % share
1 PRIVREDNA BANKA ZAGREB D.D./PRIVREDNA BANKA ZAGREB D.D. 26.92 %
2 ZAGREBAČKA BANKA D.D./EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT 16.67 %
3 ERSTE & STEIERMARKISCHE BANK D.D./ERSTE & STEIERMARKISCHE BANK D.D. 14.88 %
4 OTP BANKA D.D./OTP BANKA D.D. 8.17 %
5 ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA A 5.00 %
6 PODRAVSKA BANKA D.D./PODRAVSKA BANKA D.D. 4.50 %
7 RAIFFEISENBANK AUSTRIA D.D./RAIFFEISEN DOBROVOLJNI MIROVINSKI FOND 4.00 %
8 HPB D.D./FOND ZA FINANCIRANJE RAZGRADNJE NEK 3.33 %
9 ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA B 3.33 %
10 PRIVREDNA BANKA ZAGREB D.D./RAIFFEISEN OMF KATEGORIJE A 2.29 %
  • Account owner (holder) / Security co-holder (holder)
  • % share
  • PRIVREDNA BANKA ZAGREB D.D./PRIVREDNA BANKA ZAGREB D.D.
  • 26.92
  • ZAGREBAČKA BANKA D.D./EUROPEAN BANK FOR RECONSTRUCTION AND DEVELOPMENT
  • 16.67
  • ERSTE & STEIERMARKISCHE BANK D.D./ERSTE & STEIERMARKISCHE BANK D.D.
  • 14.88
  • OTP BANKA D.D./OTP BANKA D.D.
  • 8.17
  • ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA A
  • 5.00
  • PODRAVSKA BANKA D.D./PODRAVSKA BANKA D.D.
  • 4.50
  • RAIFFEISENBANK AUSTRIA D.D./RAIFFEISEN DOBROVOLJNI MIROVINSKI FOND
  • 4.00
  • HPB D.D./FOND ZA FINANCIRANJE RAZGRADNJE NEK
  • 3.33
  • ERSTE & STEIERMARKISCHE BANK D.D./PBZ CO OMF - KATEGORIJA B
  • 3.33
  • PRIVREDNA BANKA ZAGREB D.D./RAIFFEISEN OMF KATEGORIJE A
  • 2.29
JADRAN - GALENSKI LABORATORIJ d. d.
 
  • Home Member State
  • Hrvatska (Croatia)
  • Address
  • Svilno 20
  • City
  • 51000 Rijeka
  • Contact Person
  • Katja Cofek Pervan
  • Contact Phone
  • 051/660 700
 
  • Share Capital
  • 16,865,524.00 EUR
  • LEI
  • 529900NRAH6YWL3TLD24
  • Tax Number
  • 20950636972

JGL is the largest domestic pharmaceutical company in Croatia with a leading global position in three key therapeutic areas – flu and cold, ophthalmology and dermatology. Over 30 years, JGL has been growing and developing business around the world, and thanks to constant investment in research and development, production facilities and hi-tech technology, in accordance with ESG business principles, the company ranks among the leading producers of sterile pharmaceutical forms in the EU.

Aqua Maris, as a leading brand of the company was launched in 1999 and consists of 100 percent natural products based on seawater from the Adriatic Sea for the prevention and treatment of Upper respiratory tract infections. These are the first medicinal products in the world proven to be free of microplastics. Other key brands are Vizol S, Meralys, Aknekutan and Dramina.

More information is available on our website: www.jgl.hr

All Listed Instruments
Symbol Price Change
{{item.symbol}} {{formatNumeric(item.last_price)}} {{plusMinus(item.change_prev_close_percentage) + formatPromjena(item.change_prev_close_percentage)}}
All Delisted Securities
Symbol ISIN
3JDG HRJDGLO20CA4
3JDG2 HRJDGLO24XA2
JDGL-O-126A HRJDGLO126A5
JDGL-O-166A HRJDGLO166A1
Announcements
Historical Data

Model

Price List